These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 5008310

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Reactivity of DR xenoantisera in a cytotoxic test with human complement.
    Belvedere M, Olivetti E, Pellegrino MA, Ferrone S.
    Transplant Proc; 1979 Jun; 11(2):1327-8. PubMed ID: 314179
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identification of lymphocyte-dependent antibody in sera from multiply transfused patients.
    Yust I, Wunderlich JR, Mann DL, Terry WD.
    Transplantation; 1974 Aug; 18(2):99-107. PubMed ID: 4211029
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The cytotoxic effect on human lymphocytes of rabbit antisera to human Fc (IgG).
    Welsh KI, Cresswell P, Goujet C, Sanderson AR.
    Transplantation; 1971 Dec; 12(6):468-71. PubMed ID: 5165966
    [No Abstract] [Full Text] [Related]

  • 29. Anti-tumour antibodies in normal mouse sera.
    Martin SE, Martin WJ.
    Int J Cancer; 1975 Apr 15; 15(4):658-64. PubMed ID: 1140865
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Limited heterogeneity of antibodies against the para-azobenzoate (X p ) hapten.
    Hoffman DR, Grossberg AL, Pressman D.
    J Immunol; 1971 Aug 15; 107(2):325-30. PubMed ID: 5568764
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations.
    Gelfand EW, Resch K, Prester M.
    Eur J Immunol; 1972 Oct 15; 2(5):419-24. PubMed ID: 5084393
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The estimation of human tumors sensitivity to cytostatic treatment. II. The influencing of 125-I iododeoxyuridine incorporation by cytostatics in experimental tumors.
    Andrýsek O, Motycka K, Dvorák O, Jandová A, Stránská E.
    Neoplasma; 1969 Oct 15; 16(1):57-61. PubMed ID: 5786510
    [No Abstract] [Full Text] [Related]

  • 38. The effect of antibodies to complement components C2, C3 and C5 on the production and action of lymphotoxin.
    Gately MK, Mayer MM.
    J Immunol; 1972 Oct 15; 109(4):728-34. PubMed ID: 5074329
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.